Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Cash Flow Quality Index
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow Quality Index of 3.52x as of September 2025. Operating cash flow of CN¥201.83 Million exceeds net income of CN¥57.27 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Jiangsu Kanion Pharmaceutical Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Quality Index (2001–2024)
Historical Cash Flow Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Jiangsu Kanion Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year earnings quality comparison for Jiangsu Kanion Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 600557 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.84x | CN¥702.49 Million | CN¥380.92 Million | ▲ +1.8% |
| 2023 | 1.81x | CN¥972.32 Million | CN¥536.73 Million | ▼ -21.0% |
| 2022 | 2.29x | CN¥995.94 Million | CN¥434.47 Million | ▼ -18.1% |
| 2021 | 2.80x | CN¥908.30 Million | CN¥324.35 Million | ▲ +9.5% |
| 2020 | 2.56x | CN¥701.10 Million | CN¥274.03 Million | ▲ +42.8% |
| 2019 | 1.79x | CN¥925.73 Million | CN¥516.51 Million | ▲ +23.2% |
| 2018 | 1.45x | CN¥636.39 Million | CN¥437.60 Million | ▲ +43.6% |
| 2017 | 1.01x | CN¥382.93 Million | CN¥378.18 Million | ▲ +27.4% |
| 2016 | 0.79x | CN¥299.02 Million | CN¥376.15 Million | ▼ -43.6% |
| 2015 | 1.41x | CN¥514.80 Million | CN¥365.24 Million | ▲ +46.2% |
| 2014 | 0.96x | CN¥311.54 Million | CN¥323.11 Million | ▼ -25.3% |
| 2013 | 1.29x | CN¥388.11 Million | CN¥300.68 Million | ▲ +46.1% |
| 2012 | 0.88x | CN¥212.11 Million | CN¥240.14 Million | ▲ +85.6% |
| 2011 | 0.48x | CN¥90.19 Million | CN¥189.46 Million | ▼ -47.6% |
| 2010 | 0.91x | CN¥166.40 Million | CN¥183.21 Million | ▲ +766.2% |
| 2009 | -0.14x | CN¥-21.87 Million | CN¥160.40 Million | ▼ -133.4% |
| 2008 | 0.41x | CN¥58.39 Million | CN¥142.99 Million | ▼ -57.0% |
| 2007 | 0.95x | CN¥92.73 Million | CN¥97.57 Million | ▼ -43.1% |
| 2006 | 1.67x | CN¥108.98 Million | CN¥65.21 Million | ▼ -17.8% |
| 2005 | 2.03x | CN¥101.44 Million | CN¥49.89 Million | ▲ +346.9% |
| 2004 | 0.45x | CN¥21.68 Million | CN¥47.66 Million | ▼ -2.2% |
| 2003 | 0.47x | CN¥17.13 Million | CN¥36.81 Million | ▼ -12.7% |
| 2002 | 0.53x | CN¥11.15 Million | CN¥20.93 Million | ▼ -53.2% |
| 2001 | 1.14x | CN¥21.02 Million | CN¥18.45 Million | — |